Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp KW, Scheepers HC, Bremer HA, Rijnders RJ, van Loon AJ, Perquin DA, Sporken JM, Papatsonis DN, van Huizen ME, Vredevoogd CB, Brons JT, Kaplan M, van Kaam AH, Groen H, Porath MM, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Lancet. 2015 Jun 20;385(9986):2492-501. doi: 10.1016/S0140-6736(14)61998-X. Epub 2015 Mar 25. Lancet. 2015. PMID: 25817374 Clinical Trial.
An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp K, Scheepers H, Bremer HA, Rijnders R, van Loon AJ, Perquin D, Sporken J, Papatsonis D, van Huizen ME, Vredevoogd CB, Brons J, Kaplan M, van Kaam AH, Groen H, Porath M, van den Berg PP, Mol B, Franssen M, Langenveld J; HYPITAT-II Study Group. van Baaren GJ, et al. Among authors: broekhuijsen k. BJOG. 2017 Feb;124(3):453-461. doi: 10.1111/1471-0528.13957. Epub 2016 Mar 10. BJOG. 2017. PMID: 26969198 Clinical Trial.
Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
Bernardes TP, Broekhuijsen K, Koopmans CM, Boers KE, van Wyk L, Tajik P, van Pampus MG, Scherjon SA, Mol BW, Franssen MT, van den Berg PP, Groen H. Bernardes TP, et al. Among authors: broekhuijsen k. BJOG. 2016 Aug;123(9):1501-8. doi: 10.1111/1471-0528.14028. Epub 2016 May 13. BJOG. 2016. PMID: 27173131
Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.
Bernardes TP, Zwertbroek EF, Broekhuijsen K, Koopmans C, Boers K, Owens M, Thornton J, van Pampus MG, Scherjon SA, Wallace K, Langenveld J, van den Berg PP, Franssen MTM, Mol BWJ, Groen H. Bernardes TP, et al. Among authors: broekhuijsen k. Ultrasound Obstet Gynecol. 2019 Apr;53(4):443-453. doi: 10.1002/uog.20224. Ultrasound Obstet Gynecol. 2019. PMID: 30697855 Free PMC article.
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
Langenveld J, Broekhuijsen K, van Baaren GJ, van Pampus MG, van Kaam AH, Groen H, Porath M, Oudijk MA, Bloemenkamp KW, Groot CJ, van Beek E, van Huizen ME, Oosterbaan HP, Willekes C, Wijnen-Duvekot EJ, Franssen MT, Perquin DA, Sporken JM, Woiski MD, Bremer HA, Papatsonis DN, Brons JT, Kaplan M, Nij Bijvanck BW, Mol BW; HYPITAT-II study group. Langenveld J, et al. Among authors: broekhuijsen k. BMC Pregnancy Childbirth. 2011 Jul 7;11:50. doi: 10.1186/1471-2393-11-50. BMC Pregnancy Childbirth. 2011. PMID: 21736705 Free PMC article. Clinical Trial.
Relevance of individual participant data meta-analysis for studies in obstetrics: delivery versus expectant monitoring for hypertensive disorders of pregnancy.
Broekhuijsen K, Bernardes T, van Baaren GJ, Tajik P, Novikova N, Thangaratinam S, Boers K, Koopmans CM, Wallace K, Shennan AH, Langenveld J, Groen H, van den Berg PP, Mol BW, Franssen MT. Broekhuijsen K, et al. Eur J Obstet Gynecol Reprod Biol. 2015 Aug;191:80-3. doi: 10.1016/j.ejogrb.2015.05.023. Epub 2015 Jun 3. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 26094180 Review.
Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy.
Zwertbroek EF, Broekhuijsen K, Langenveld J, van Baaren GJ, van den Berg PP, Bremer HA, Ganzevoort W, van Loon AJ, Mol BW, van Pampus MG, Perquin DA, Rijnders RJ, Scheepers HC, Sikkema MJ, Woiski MD, Groen H, Franssen MT; HYPITAT-II Study Group. Zwertbroek EF, et al. Among authors: broekhuijsen k. Acta Obstet Gynecol Scand. 2017 Jan;96(1):96-105. doi: 10.1111/aogs.13051. Acta Obstet Gynecol Scand. 2017. PMID: 27792243 Free article.
Gestational hypertension and advanced maternal age - Authors' reply.
Broekhuijsen K, Groen H, van den Berg PP, Mol BW, Franssen MT, Langenveld J; HYPITAT-II study group. Broekhuijsen K, et al. Lancet. 2015 Oct 24;386(10004):1628. doi: 10.1016/S0140-6736(15)00533-4. Lancet. 2015. PMID: 26595632 No abstract available.
Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
Zwertbroek EF, Franssen MTM, Broekhuijsen K, Langenveld J, Bremer H, Ganzevoort W, van Loon AJ, van Pampus MG, Rijnders RJP, Sikkema MJ, Scherjon SA, Woiski MD, Mol BWJ, van Baar AL, Groen H; HYPITAT-II Study Group. Zwertbroek EF, et al. Among authors: broekhuijsen k. Am J Obstet Gynecol. 2019 Aug;221(2):154.e1-154.e11. doi: 10.1016/j.ajog.2019.03.024. Epub 2019 Mar 30. Am J Obstet Gynecol. 2019. PMID: 30940558 Clinical Trial.
16 results